“…Changes occurring in most neurodegenerative conditions were the high expression of a group of transcripts encoding the lysososmal cathepsin inhibitor Cystatin F (Cst7) (Ma et al, 2011), osteopontin (Spp1), an opsonin for cell debris (Shin et al, 2011), and cholesterol 25-hydroxylase (Ch25h) that, through its product, 25-hydroxycholesterol, activates the LXR pathway and promotes ROS production and inflammation (Jang et al, 2016). Underexpression of neuroprotective (Clec4a1, Il16) (Flytzani et al, 2013, Shrestha et al, 2014 and anti-inflammatory (Klf2, Gramd4, Ddit4, Pirb, Tsc22d3) (Roberts et al, 2017, Ip et al, 2017, Kimura et al, 2015, Zhang et al, 2005, Berrebi et al, 2003 transcripts was observed in ALSP and at least three other conditions ( Fig. 5H).…”